Business Description
Guerbet SA
NAICS : 334510
ISIN : FR0013079951
Compare
Compare
Traded in other countries / regions
GBT.France4G8.Germany0ELV.UKGUERF.USA IPO Date
2016-01-05Description
Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.27 | |||||
| Equity-to-Asset | 0.4 | |||||
| Debt-to-Equity | 0.82 | |||||
| Debt-to-EBITDA | 3.13 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.26 | |||||
| Beneish M-Score | -3.05 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -2 | |||||
| 3-Year EBITDA Growth Rate | -5.2 | |||||
| 3-Year Book Growth Rate | -0.9 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.13 | |||||
| Quick Ratio | 0.99 | |||||
| Cash Ratio | 0.35 | |||||
| Days Inventory | 411.06 | |||||
| Days Sales Outstanding | 58.64 | |||||
| Days Payable | 156.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 15 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 72.56 | |||||
| Operating Margin % | -0.46 | |||||
| Net Margin % | -5.34 | |||||
| ROE % | -10.16 | |||||
| ROA % | -4.19 | |||||
| ROIC % | -0.69 | |||||
| ROC (Joel Greenblatt) % | -5.3 | |||||
| ROCE % | -3.21 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 7.68 | |||||
| PS Ratio | 0.29 | |||||
| PB Ratio | 0.58 | |||||
| Price-to-Tangible-Book | 0.78 | |||||
| Price-to-Operating-Cash-Flow | 7.14 | |||||
| EV-to-EBIT | -18.89 | |||||
| EV-to-EBITDA | 4.53 | |||||
| EV-to-Revenue | 0.58 | |||||
| EV-to-FCF | -22.39 | |||||
| Price-to-Projected-FCF | 0.45 | |||||
| Price-to-Median-PS-Value | 0.33 | |||||
| Earnings Yield (Greenblatt) % | -5.29 | |||||
| Forward Rate of Return (Yacktman) % | 6.19 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Guerbet SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 769.498 | ||
| EPS (TTM) (€) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0 | ||
| 20-Day SMA (€) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 53 - 73.1 | ||
| Shares Outstanding (Mil) | 12.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Guerbet SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Guerbet SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Guerbet SA Frequently Asked Questions
What is Guerbet SA(XPAR:GBTNV)'s stock price today?
The current price of XPAR:GBTNV is €60.00. The 52 week high of XPAR:GBTNV is €73.10 and 52 week low is €53.00.
When is next earnings date of Guerbet SA(XPAR:GBTNV)?
The next earnings date of Guerbet SA(XPAR:GBTNV) is .
Does Guerbet SA(XPAR:GBTNV) pay dividends? If so, how much?
Guerbet SA(XPAR:GBTNV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers